New York State Common Retirement Fund’s Achillion Pharmaceuticals ACHN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-113,900
| Closed | -$687K | – | 3215 |
|
|
2019
Q4 | $687K | Sell |
113,900
-15,800
| -12% | -$91.5K | ﹤0.01% | 2136 |
|
|
2019
Q3 | $467K | Hold |
129,700
| – | – | ﹤0.01% | 2369 |
|
|
2019
Q2 | $348K | Hold |
129,700
| – | – | ﹤0.01% | 2543 |
|
|
2019
Q1 | $384K | Hold |
129,700
| – | – | ﹤0.01% | 2426 |
|
|
2018
Q4 | $206K | Sell |
129,700
-17,100
| -12% | -$48.3K | ﹤0.01% | 2701 |
|
|
2018
Q3 | $540K | Hold |
146,800
| – | – | ﹤0.01% | 2376 |
|
|
2018
Q2 | $415K | Hold |
146,800
| – | – | ﹤0.01% | 2528 |
|
|
2018
Q1 | $545K | Buy |
146,800
+28,500
| +24% | +$93.3K | ﹤0.01% | 2310 |
|
|
2017
Q4 | $341K | Hold |
118,300
| – | – | ﹤0.01% | 2524 |
|
|
2017
Q3 | $531K | Hold |
118,300
| – | – | ﹤0.01% | 2325 |
|
|
2017
Q2 | $543K | Sell |
118,300
-16,001
| -12% | -$64.3K | ﹤0.01% | 2366 |
|
|
2017
Q1 | $565K | Buy |
134,301
+1
| +0% | +$4 | ﹤0.01% | 2330 |
|
|
2016
Q4 | $555K | Hold |
134,300
| – | – | ﹤0.01% | 2330 |
|
|
2016
Q3 | $1.09M | Buy |
134,300
+6,600
| +5% | +$56.1K | ﹤0.01% | 1959 |
|
|
2016
Q2 | $996K | Hold |
127,700
| – | – | ﹤0.01% | 1965 |
|
|
2016
Q1 | $986K | Hold |
127,700
| – | – | ﹤0.01% | 1961 |
|
|
2015
Q4 | $1.38M | Hold |
127,700
| – | – | ﹤0.01% | 1798 |
|
|
2015
Q3 | $882K | Sell |
127,700
-9,696
| -7% | -$79K | ﹤0.01% | 2017 |
|
|
2015
Q2 | $1.22M | Buy |
137,396
+121,396
| +759% | +$1.15M | ﹤0.01% | 2077 |
|
|
2015
Q1 | $158K | Buy |
+16,000
| New | +$200K | ﹤0.01% | 2182 |
|
New York State Common Retirement Fund's ACHN Position: Q1 2020 in Review
New York State Common Retirement Fund sold out of Achillion Pharmaceuticals (ACHN) in Q1 2020, closing a stake of 113,900 shares — an estimated $687K sold.
New York State Common Retirement Fund first reported a position in ACHN in Q1 2015 and held it in 20 quarters. The position peaked at $1.38M in Q4 2015. 0 funds tracked by Wall St. Rank hold ACHN as of Q1 2020.
- New York State Common Retirement Fund reported no remaining Achillion Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
- New York State Common Retirement Fund sold 113,900 Achillion Pharmaceuticals shares in Q1 2020, an estimated $687K.
- New York State Common Retirement Fund first reported a position in Achillion Pharmaceuticals in Q1 2015 and held it in 20 quarters.
- New York State Common Retirement Fund's Achillion Pharmaceuticals position peaked at $1.38M in Q4 2015.
- 0 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q1 2020.
Based on New York State Common Retirement Fund's 13F filing for Q1 2020, filed 6 May 2020.